{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:21:39Z","timestamp":1790029299715,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,19]]},"DOI":"10.7759\/cureus.49078","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:33:22Z","timestamp":1700462002000},"source":"Crossref","is-referenced-by-count":4,"title":["Liver Disease-Related Sarcopenia: A Predictor of Poor Prognosis by Accelerating Hepatic Decompensation in Advanced Chronic Liver Disease"],"prefix":"10.7759","author":[{"given":"Atsushi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola M","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019, 65:37-55. 10.1016\/j.mam.2018.09.002","journal-title":"Mol Aspects Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana L","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017, 37:1-10. 10.1055\/s-0036-1597816","journal-title":"Semin Liver Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba R","year":"2020","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020, 69:1343-52. 10.1136\/gutjnl-2018-317593","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0012-0","article-title":"When and how to use magnetic resonance elastography for patients with liver disease in clinical practice","volume":"113","author":"Venkatesh SK","year":"2018","unstructured":"Venkatesh SK, Talwalkar JA. When and how to use magnetic resonance elastography for patients with liver disease in clinical practice. Am J Gastroenterol. 2018, 113:923-6. 10.1038\/s41395-018-0012-0","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16745","article-title":"Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality","volume":"55","author":"Higuchi M","year":"2022","unstructured":"Higuchi M, Tamaki N, Kurosaki M, et al.. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022, 55:292-301. 10.1111\/apt.16745","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32151","article-title":"Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study","volume":"75","author":"Gidener T","year":"2022","unstructured":"Gidener T, Yin M, Dierkhising RA, Allen AM, Ehman RL, Venkatesh SK. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study. Hepatology. 2022, 75:379-90. 10.1002\/hep.32151","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"56","author":"Yoshiji H","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, et al.. Evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021, 56:593-619. 10.1007\/s00535-021-01788-x","journal-title":"J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai JC","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1611-44. 10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12869","article-title":"Sarcopenia as a prognostic indicator of liver cirrhosis","volume":"13","author":"Kim SE","year":"2022","unstructured":"Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle. 2022, 13:8-10. 10.1002\/jcsm.12869","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2761w","article-title":"Insulin-like growth factor-1 deficiency and cirrhosis establishment","volume":"9","author":"de la Garza RG","year":"2017","unstructured":"de la Garza RG, Morales-Garza LA, Martin-Estal I, Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and cirrhosis establishment. J Clin Med Res. 2017, 9:233-47. 10.14740\/jocmr2761w","journal-title":"J Clin Med Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103239","article-title":"Low serum branched-chain amino acid and insulin-like growth factor-1 levels are associated with sarcopenia and slow gait speed in patients with liver cirrhosis","volume":"9","author":"Saeki C","year":"2020","unstructured":"Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Low serum branched-chain amino acid and insulin-like growth factor-1 levels are associated with sarcopenia and slow gait speed in patients with liver cirrhosis. J Clin Med. 2020, 9:3239. 10.3390\/jcm9103239","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29602","article-title":"Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis","volume":"67","author":"Praktiknjo M","year":"2018","unstructured":"Praktiknjo M, Book M, Luetkens J, et al.. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology. 2018, 67:1014-26. 10.1002\/hep.29602","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24676","article-title":"Diagnosis and pathogenesis of sarcopenia in chronic liver disease using liver magnetic resonance imaging","volume":"14","author":"Nakamura A","year":"2022","unstructured":"Nakamura A, Yoshimura T, Sato T, Ichikawa T. Diagnosis and pathogenesis of sarcopenia in chronic liver disease using liver magnetic resonance imaging. Cureus. 2022, 14:e24676. 10.7759\/cureus.24676","journal-title":"Cureus"},{"key":"ref14","article-title":"[A national surveillance study on alcoholic liver disease in Japan (1986-1991)]","volume":"91","author":"Takada A","year":"1994","unstructured":"Takada A, Matsuda Y, Takase S, et al.. [A national surveillance study on alcoholic liver disease in Japan (1986-1991)]. Nihon Shokakibyo Gakkai Zasshi. 1994, 91:887-98.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo K","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, et al.. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016, 150:626-637.e7. 10.1053\/j.gastro.2015.11.048","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero JA","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al.. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018, 68:723-50. 10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13411","article-title":"Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update","volume":"49","author":"Kokudo N","year":"2019","unstructured":"Kokudo N, Takemura N, Hasegawa K, et al.. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019, 49:1109-13. 10.1111\/hepr.13411","journal-title":"Hepatol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson PJ","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al.. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015, 33:550-8. 10.1200\/JCO.2014.57.9151","journal-title":"J Clin Oncol"},{"key":"ref19","article-title":"[Multicystic dysplasia of the kidney in children. Apropos of 45 cases]","volume":"79","author":"Cendron J","year":"1973","unstructured":"Cendron J, Gubler JP, Valayer J, Kiriakos S. [Multicystic dysplasia of the kidney in children. Apropos of 45 cases]. J Urol Nephrol (Paris). 1973, 79:773-99.","journal-title":"J Urol Nephrol (Paris)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000488778","article-title":"Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis","volume":"8","author":"Hiraoka A","year":"2019","unstructured":"Hiraoka A, Kumada T, Tsuji K, et al.. Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis. Liver Cancer. 2019, 8:121-9. 10.1159\/000488778","journal-title":"Liver Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.06.012","article-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","volume":"5","author":"Yin M","year":"2007","unstructured":"Yin M, Talwalkar JA, Glaser KJ, et al.. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007, 5:1207-1213.e2. 10.1016\/j.cgh.2007.06.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20831","article-title":"Water-fat separation with IDEAL gradient-echo imaging","volume":"25","author":"Reeder SB","year":"2007","unstructured":"Reeder SB, McKenzie CA, Pineda AR, et al.. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007, 25:644-52. 10.1002\/jmri.20831","journal-title":"J Magn Reson Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu C","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K, et al.. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019, 17:630-637.e8. 10.1016\/j.cgh.2018.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25868","article-title":"Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging","volume":"47","author":"Morisaka H","year":"2018","unstructured":"Morisaka H, Motosugi U, Ichikawa S, et al.. Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging. J Magn Reson Imaging. 2018, 47:1268-75. 10.1002\/jmri.25868","journal-title":"J Magn Reson Imaging"},{"key":"ref25","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ul\u00edbarri J","year":"2005","unstructured":"Ignacio de Ul\u00edbarri J, Gonz\u00e1lez-Madro\u00f1o A, de Villar NG, et al.. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005, 20:38-45.","journal-title":"Nutr Hosp"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej12-0110","article-title":"Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method","volume":"59","author":"Isojima T","year":"2012","unstructured":"Isojima T, Shimatsu A, Yokoya S, et al.. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J. 2012, 59:771-80. 10.1507\/endocrj.ej12-0110","journal-title":"Endocr J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22242","article-title":"Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma","volume":"107","author":"Lu SN","year":"2006","unstructured":"Lu SN, Wang JH, Liu SL, et al.. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer. 2006, 107:2212-22. 10.1002\/cncr.22242","journal-title":"Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9 HJ","year":"2000","unstructured":"Adrogu\u00e9 HJ, Madias NE. Hyponatremia. N Engl J Med. 2000, 342:1581-9. 10.1056\/NEJM200005253422107","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26905","article-title":"Normal range for MR elastography measured liver stiffness in children without liver disease","volume":"51","author":"Sawh MC","year":"2020","unstructured":"Sawh MC, Newton KP, Goyal NP, et al.. Normal range for MR elastography measured liver stiffness in children without liver disease. J Magn Reson Imaging. 2020, 51:919-27. 10.1002\/jmri.26905","journal-title":"J Magn Reson Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13927","article-title":"Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease","volume":"33","author":"Abe K","year":"2018","unstructured":"Abe K, Takahashi A, Imaizumi H, et al.. Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease. J Gastroenterol Hepatol. 2018, 33:733-40. 10.1111\/jgh.13927","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.21.2564","article-title":"Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage","volume":"161","author":"Zaman A","year":"2001","unstructured":"Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001, 161:2564-70. 10.1001\/archinte.161.21.2564","journal-title":"Arch Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis R","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022, 76:959-74. 10.1016\/j.jhep.2021.12.022","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100513","article-title":"Risk of further decompensation\/mortality in patients with cirrhosis and ascites as the first single decompensation event","volume":"4","author":"Balcar L","year":"2022","unstructured":"Balcar L, Tonon M, Semmler G, et al.. Risk of further decompensation\/mortality in patients with cirrhosis and ascites as the first single decompensation event. JHEP Rep. 2022, 4:100513. 10.1016\/j.jhepr.2022.100513","journal-title":"JHEP Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.03.065","article-title":"Outcomes and mortality of grade 1 ascites and recurrent ascites in patients with cirrhosis","volume":"19","author":"Tonon M","year":"2021","unstructured":"Tonon M, Piano S, Gambino CG, et al.. Outcomes and mortality of grade 1 ascites and recurrent ascites in patients with cirrhosis. Clin Gastroenterol Hepatol. 2021, 19:358-366.e8. 10.1016\/j.cgh.2020.03.065","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.016","article-title":"Role of magnetic resonance elastography in compensated and decompensated liver disease","volume":"60","author":"Asrani SK","year":"2014","unstructured":"Asrani SK, Talwalkar JA, Kamath PS, et al.. Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol. 2014, 60:934-9. 10.1016\/j.jhep.2013.12.016","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13263","article-title":"Performance of magnetic resonance elastography in primary sclerosing cholangitis","volume":"31","author":"Eaton JE","year":"2016","unstructured":"Eaton JE, Dzyubak B, Venkatesh SK, et al.. Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol. 2016, 31:1184-90. 10.1111\/jgh.13263","journal-title":"J Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14593","article-title":"MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study","volume":"40","author":"Han MA","year":"2020","unstructured":"Han MA, Vipani A, Noureddin N, et al.. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. Liver Int. 2020, 40:2242-51. 10.1111\/liv.14593","journal-title":"Liver Int"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2020.111095","article-title":"Body mass index changes after transjugular intrahepatic portosystemic shunt in individuals with cirrhosis","volume":"84","author":"Pang N","year":"2021","unstructured":"Pang N, Zhao C, Li J, et al.. Body mass index changes after transjugular intrahepatic portosystemic shunt in individuals with cirrhosis. Nutrition. 2021, 84:111095. 10.1016\/j.nut.2020.111095","journal-title":"Nutrition"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.211172","article-title":"Sarcopenia in patients with cirrhosis after transjugular intrahepatic portosystemic shunt placement","volume":"303","author":"Liu J","year":"2022","unstructured":"Liu J, Ma J, Yang C, et al.. Sarcopenia in patients with cirrhosis after transjugular intrahepatic portosystemic shunt placement. Radiology. 2022, 303:711-9. 10.1148\/radiol.211172","journal-title":"Radiology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14175","article-title":"Adipopenia correlates with higher portal pressure in patients with cirrhosis","volume":"39","author":"Rodrigues SG","year":"2019","unstructured":"Rodrigues SG, Brabandt B, Stirnimann G, Maurer MH, Berzigotti A. Adipopenia correlates with higher portal pressure in patients with cirrhosis. Liver Int. 2019, 39:1672-81. 10.1111\/liv.14175","journal-title":"Liver Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03236-y","article-title":"Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly","volume":"21","author":"Bian A","year":"2020","unstructured":"Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, Wang X. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020, 21:214. 10.1186\/s12891-020-03236-y","journal-title":"BMC Musculoskelet Disord"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.9.5994","article-title":"The effect of short stature, portal hypertension, and cholestasis on growth hormone resistance in children with liver disease","volume":"84","author":"Holt RI","year":"1999","unstructured":"Holt RI, Jones JS, Baker AJ, Buchanan CR, Miell JP. The effect of short stature, portal hypertension, and cholestasis on growth hormone resistance in children with liver disease. J Clin Endocrinol Metab. 1999, 84:3277-82. 10.1210\/jcem.84.9.5994","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins SW","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, et al.. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1014-48. 10.1002\/hep.31884","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.11.011","article-title":"The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis","volume":"55","author":"Dajti E","year":"2023","unstructured":"Dajti E, Renzulli M, Ravaioli F, et al.. The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis. Dig Liver Dis. 2023, 55:637-43. 10.1016\/j.dld.2022.11.011","journal-title":"Dig Liver Dis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s P","year":"2008","unstructured":"Gin\u00e8s P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008, 48:1002-10. 10.1002\/hep.22418","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update","volume":"115","author":"Alukal JJ","year":"2020","unstructured":"Alukal JJ, John S, Thuluvath PJ. Hyponatremia in cirrhosis: an update. Am J Gastroenterol. 2020, 115:1775-85. 10.14309\/ajg.0000000000000786","journal-title":"Am J Gastroenterol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(96)80174-7","article-title":"Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis","volume":"24","author":"Gin\u00e8s P","year":"1996","unstructured":"Gin\u00e8s P, Jim\u00e9nez W. Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis. J Hepatol. 1996, 24:506-12. 10.1016\/s0168-8278(96)80174-7","journal-title":"J Hepatol"},{"key":"ref48","article-title":"Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents","volume":"6","author":"Leiva JG","year":"2007","unstructured":"Leiva JG, Salgado JM, Estradas J, Torre A, Uribe M. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents. Ann Hepatol. 2007, 6:214-21.","journal-title":"Ann Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis [Online ahead of print]","author":"Kaplan DE","year":"2023","unstructured":"Kaplan DE, Bosch J, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis [Online ahead of print]. Hepatology. 2023, 10.1097\/HEP.0000000000000647","journal-title":"Hepatology"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44419","article-title":"Mildly low serum sodium levels in chronic liver disease: at risk for sarcopenia and portal hypertension","volume":"15","author":"Nakamura A","year":"2023","unstructured":"Nakamura A, Yoshimura T, Ichikawa T. Mildly low serum sodium levels in chronic liver disease: at risk for sarcopenia and portal hypertension. Cureus. 2023, 15:e44419. 10.7759\/cureus.44419","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/122447-liver-disease-related-sarcopenia-a-predictor-of-poor-prognosis-by-accelerating-hepatic-decompensation-in-advanced-chronic-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:44Z","timestamp":1707508364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/122447-liver-disease-related-sarcopenia-a-predictor-of-poor-prognosis-by-accelerating-hepatic-decompensation-in-advanced-chronic-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,19]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.49078","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,19]]}}}